News | February 25, 2015

Pencil beam scanning, breath-hold device among new innovations

SCCA, proton therapy, radiation, RaySearch, RayStation, Active Breathing

February 25, 2015 — Physicians treating patients with complex tumors will have more advanced treatment options at Seattle Cancer Care Alliance Proton Therapy, a ProCure Center. The center will now offer pencil beam scanning (PBS) in its state-of-the-art gantry room. The combination of proton therapy with PBS technology enables physicians to better shape and direct radiation to the tumor, opening the doors to treat a wider variety of cancers.

“PBS is the most advanced way to deliver proton radiation and will allow us to sculpt protons for treating more complex tumors, such as in the head and neck, lung, abdomen, and pelvic areas,” said Smith ‘Jim’ Apisarnthanarax, M.D., a radiation oncologist at SCCA Proton Therapy.

SCCA Proton Therapy has also recently become the first proton center to use an advanced breath-hold device that aids patients in their ability to control breathing during radiation treatment. The Active Breathing Coordinator (ABC) device may be used when treating tumors in the chest or abdomen that move with breathing. It assists patients with systematically holding their breath before or after they’ve breathed out.

During this brief time, the ABC device makes the tumor a stationary target, allowing the treatment to be even more accurate, sparing surrounding tissue. The device’s ability to control breath both on inhale and exhale allows physicians to treat a range of tumors.

In addition, University of Washington Medicine physicians and SCCA Proton Therapy physicists are working together to upgrade the process for developing PBS patient treatment plans with RaySearch Laboratories‘ advanced treatment-planning and dose-tracking software platform, RayStation. RayStation combines the capabilities of traditional imaging such as computed tomography (CT), positron emission tomography (PET) and magnetic resonance imaging (MRI), with contouring and 4-D compatibility. Other features include multi-criteria optimization, dose tracking, treatment adaptation and near-real-time deformable image registration.

“Providing patients with the best treatment possible is our No. 1 priority and we believe investing in these advancements allows us to provide them with the highest levels of care,” said Ramesh Rengan, M.D., medical director at SCCA Proton Therapy. “These innovative technologies will make treatments more effective for patients, while shortening the overall treatment course for select cancers.”

For more information: www.sccaprotontherapy.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now